Image

SPINE BONE CEMENTS OUTCOMES

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

A Post-Market Clinical Follow-Up (PMCF) Study to collect clinical data on safety and performance of all TEKNIMED Spine range of products: SPINEFIX, HIGH V+, OPACITY+ and F20 bone cements and mixing and injection systems, and all their private labels.

TEKNIMED bone cements are legacy products, some marketed for more than 10 years. Their performance and safety have already been demonstrated by Post-Market Surveillance and previous clinical studies. The current Post-Market Clinical Follow-Up study aims to confirm these claims by collecting data in a "real-life" setting.

The study is a retrospective and prospective global, single arm, non-controlled, multicentric, prospective observational study. Patients will be followed as per local standard medical care of the sites.

Description

It is admitted that:

  • Cementoplasty procedures such as vertebroplasty and kyphoplasty are recommended in the treatment of painful vertebral compression fractures, due to their efficiency and safety
  • These mini-invasive procedures, where bone cement is injected into a partially collapsed vertebral body, are used to reduce pain and to provide mechanical stability
  • In most patients, a rapid pain relief and an increase in mobility and quality of life are obtained
  • Serious complications from bone cements leaks and adjacent vertebral fractures can be observed but remain rather rare
  • The use of spinal cement in pedicle screw augmentation procedures can be relevant to increase the strength of the screw fixation in the bone, particularly in osteoporotic patients.

TEKNIMED has developed several bone cements currently used in vertebroplasty and kyphoplasty procedures in the treatment of vertebral weakness. Among those, one cement is also used in pedicle screw augmentation procedures.

With the increasing use of these procedures, there is a need of real-life safety and efficacy data on the bone cements.

This retro-prospective study is performed to confirm the safety and performance of TEKNIMED spine bone cements in their current clinical use.

Eligibility

Inclusion Criteria:

  • Be 18 years or older
  • Be willing to sign an informed consent approved by Ethic Committee (when applicable) or not being opposed to the use of their clinical data in the study
    • For prospective inclusion:
  • Be considered for treatment with one of the TEKNIMED Spine Range cement comprised in

    this study

    • For retrospective inclusion:
  • Have undergone a surgery with a TEKNIMED Spine Range cement between the 1st of January

    2016 and the date of the site initiation visit.

  • Be informed of the study and not being opposed to the use of their clinical data in the study or be willing to sign an informed consent during the first follow-up visit following the site initiation (when applicable).

Exclusion Criteria:

        Patients presenting one of the following conditions will not be included (contraindications
        per IFU):
          -  Procedures other than those stated in the INDICATIONS section
          -  Coagulation disorders, or severe cardiopulmonary disease
          -  Unstable vertebral fractures
          -  Compromise of the vertebral body or of the pedicle walls
          -  Hypersensitivity or allergy to one of the constituents of the product
          -  Patient clearly improving on more conservative treatment
          -  Prophylactic use in spinal metastatic or osteoporotic patients with no evidence of
             acute fracture
          -  Paediatric patients and pregnant or breast-feeding women.

Study details

Vertebral Fracture, Compression Fracture, Osteoporotic Fractures

NCT06367582

Teknimed

29 April 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.